Those in the know please respond - is there any drug
currently in use that would compete w/ Drox.? With
what we've seen so far in 302 trial do we have an
advantage at this point as a therapy over this drug.
If there is no existing therapy wouldn't this weigh
on the FDA's decision to change the trial criteria.
This seems like a better than 50/50 chance of a
change to me just from a common sense approach. See
all longs at the bank for a deposite in the months
ahead.